zoledronic acid has been researched along with HbS Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalle Carbonare, L; De Franceschi, L; Matte', A; Mori, A; Perbellini, L; Schweiger, V; Siciliano, A; Valenti, MT; Zampieri, G | 1 |
1 other study(ies) available for zoledronic acid and HbS Disease
Article | Year |
---|---|
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease.
Topics: Anemia, Sickle Cell; Animals; Bone Diseases; Cathepsin K; Core Binding Factor Alpha 1 Subunit; Diphosphonates; Disease Models, Animal; Humans; Imidazoles; Interleukin-6; Mice; Mice, Transgenic; Osteoclasts; Osteonectin; RANK Ligand; Reperfusion Injury; Zoledronic Acid | 2015 |